SONOMA PHARMACEUTICALS, INC. (SNOA) Return on equity 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-102.6%FY2026 · since FY2017: 43.3% → -102.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -102.6% | -24.2 pp |
| FY2025 | -78.4% | +0.4 pp |
| FY2024 | -78.8% | -14.2 pp |
| FY2023 | -64.6% | -6.1 pp |
| FY2022 | -58.5% | +15.2 pp |
| FY2021 | -73.7% | -14.8 pp |
| FY2020 | -58.8% | +93.0 pp |
| FY2019 | -151.8% | -58.4 pp |
| FY2018 | -93.5% | -136.8 pp |
| FY2017 | 43.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice